{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7920430", "DateCompleted": {"Year": "1994", "Month": "10", "Day": "25"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0918-6158", "JournalIssue": {"Volume": "17", "Issue": "5", "PubDate": {"Year": "1994", "Month": "May"}}, "Title": "Biological & pharmaceutical bulletin", "ISOAbbreviation": "Biol Pharm Bull"}, "ArticleTitle": "Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.", "Pagination": {"StartPage": "668", "EndPage": "671", "MedlinePgn": "668-71"}, "Abstract": {"AbstractText": ["To search for possible anti-tumor-promoters, we carried out a primary screening of 21 cucurbitane triterpenoids using an in vitro assay system. Of these triterpenoids, scandenoside R6 (6), 23,24-dihydrocucurbitacin F (14), 25-acetyl-23,24-dihydrocucurbitacin F (15), 2-O-beta-D-glucopyranosyl-23,24-dihydrocucurbitacin F (17) and cucurbitacin F (18) exhibited significant inhibitory effects on Epstein-Barr virus (EBV) activation induced by the tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA). Further, compounds 14 and 17 exhibited remarkable anti-tumor-promotion effects on mouse skin tumor promotion in an in vivo two-stage carcinogenesis test."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyoto Pharmaceutical University, Japan."}], "LastName": "Konoshima", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Takasaki", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tatsumoto", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kozuka", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kasai", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tanaka", "ForeName": "O", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nie", "ForeName": "R L", "Initials": "RL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tokuda", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nishino", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Iwashima", "ForeName": "A", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Biol Pharm Bull", "NlmUniqueID": "9311984", "ISSNLinking": "0918-6158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "NI40JAQ945", "NameOfSubstance": "Tetradecanoylphorbol Acetate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Carbohydrate Sequence"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Herpesvirus 4, Human"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": [], "DescriptorName": "Molecular Sequence Data"}, {"QualifierName": ["microbiology", "prevention & control"], "DescriptorName": "Papilloma"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetradecanoylphorbol Acetate"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Triterpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Activation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "5", "Day": "1"}, {"Year": "1994", "Month": "5", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "5", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7920430", "10.1248/bpb.17.668"]}}]}